Abstract
Ravulizumab in Adults with Generalized Myasthenia Gravis: A Sub-Analysis of the Phase 3 CHAMPION MG Study According to Chronic IVIg Use at Study Entry (P1-5.013)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have